FDA Approves Marketing of First Device to Treat ADHD

MONDAY, April 22, 2019 -- Marketing has been approved for the first medical device to treat attention-deficit/hyperactivity disorder (ADHD), the U.S. Food and Drug Administration announced Friday. The Monarch external Trigeminal Nerve Stimulation...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news